🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.20
-0.24 (-1.93%)
Nov 19, 2026, 3:30 PM EST - Market open

Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $167.45 million. The enterprise value is $84.15 million.

Market Cap167.45M
Enterprise Value 84.15M

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Korro Bio has 13.73 million shares outstanding. The number of shares has increased by 50.71% in one year.

Current Share Class 13.73M
Shares Outstanding 13.73M
Shares Change (YoY) +50.71%
Shares Change (QoQ) +1.41%
Owned by Insiders (%) 0.86%
Owned by Institutions (%) 74.09%
Float 9.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 129.93
Forward PS 83.37
PB Ratio 1.93
P/TBV Ratio 1.90
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 65.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.30, with a Debt / Equity ratio of 0.47.

Current Ratio 7.30
Quick Ratio 7.04
Debt / Equity 0.47
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -87.90

Financial Efficiency

Return on equity (ROE) is -113.26% and return on invested capital (ROIC) is -34.78%.

Return on Equity (ROE) -113.26%
Return on Assets (ROA) -30.73%
Return on Invested Capital (ROIC) -34.78%
Return on Capital Employed (ROCE) -57.15%
Weighted Average Cost of Capital (WACC) 12.85%
Revenue Per Employee $22,276
Profits Per Employee -$1.83M
Employee Count58
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, Korro Bio has paid $1.10 million in taxes.

Income Tax 1.10M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +96.62% in the last 52 weeks. The beta is 2.07, so Korro Bio's price volatility has been higher than the market average.

Beta (5Y) 2.07
52-Week Price Change +96.62%
50-Day Moving Average 11.82
200-Day Moving Average 12.16
Relative Strength Index (RSI) 44.54
Average Volume (20 Days) 204,792

Short Selling Information

The latest short interest is 1.75 million, so 12.74% of the outstanding shares have been sold short.

Short Interest 1.75M
Short Previous Month 1.73M
Short % of Shares Out 12.74%
Short % of Float 17.97%
Short Ratio (days to cover) 8.93

Income Statement

In the last 12 months, Korro Bio had revenue of $1.29 million and -$106.13 million in losses. Loss per share was -$7.50.

Revenue1.29M
Gross Profit -41.01M
Operating Income -76.12M
Pretax Income -105.03M
Net Income -106.13M
EBITDA -74.37M
EBIT -76.12M
Loss Per Share -$7.50
Full Income Statement

Balance Sheet

The company has $124.82 million in cash and investments and $41.52 million in debt, with a net cash position of $83.30 million or $6.07 per share.

Cash & Investments 124.82M
Total Debt 41.52M
Net Cash 83.30M
Net Cash Per Share $6.07
Equity (Book Value) 88.37M
Book Value Per Share 6.44
Working Capital 94.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.71 million and capital expenditures -$169,000, giving a free cash flow of -$63.87 million.

Operating Cash Flow -63.71M
Capital Expenditures -169,000
Depreciation & Amortization 1.75M
Net Borrowing n/a
Free Cash Flow -63.87M
FCF Per Share -$4.65
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -5,891.49%
Pretax Margin -8,129.41%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -50.71%
Shareholder Yield -50.71%
Earnings Yield -61.51%
FCF Yield -38.05%

Analyst Forecast

The average price target for Korro Bio is $21.50, which is 76.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target $21.50
Price Target Difference 76.23%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Korro Bio has an Altman Z-Score of -3.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.33
Piotroski F-Score 2